Iradimed (IRMD) Share-based Compensation Growth (3y) (2016 - 2026)
Iradimed (IRMD) Share-based Compensation Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.40% |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn | 12.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.39% |
| Mar 31, 2026 | 139.36% |
| Dec 31, 2025 | 84.46% |
| Sep 30, 2025 | 19.21% |
| Jun 30, 2025 | 82.10% |
| Mar 31, 2025 | -36.51% |
| Dec 31, 2024 | 18.43% |
| Sep 30, 2024 | 20.30% |
| Jun 30, 2024 | 19.38% |
| Mar 31, 2024 | 153.24% |
| Dec 31, 2023 | 83.33% |
| Sep 30, 2023 | 8.62% |
| Jun 30, 2023 | -40.20% |
| Mar 31, 2023 | -55.58% |
| Dec 31, 2022 | -8.04% |
| Sep 30, 2022 | -4.80% |
| Jun 30, 2022 | -36.31% |
| Mar 31, 2022 | 5.84% |
| Dec 31, 2021 | -6.44% |
| Sep 30, 2021 | -10.43% |